These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9034354)

  • 41. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
    Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
    Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T; Castellino FJ
    Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High affinity binding of factor XIIa to an electronegative surface controls the rates of factor XII and prekallikrein activation in vitro.
    Mitropoulos KA
    Thromb Res; 1999 Apr; 94(2):117-29. PubMed ID: 10230897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence.
    Clark CC; Hofman ZLM; Sanrattana W; den Braven L; de Maat S; Maas C
    Thromb Haemost; 2020 Mar; 120(3):400-411. PubMed ID: 31940673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
    Hu Y; Wang H; Jiao J; Wang Y; Yu W; Ling X
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):466-8. PubMed ID: 11877020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
    Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor XII/XIIa inhibitors: Their discovery, development, and potential indications.
    Davoine C; Bouckaert C; Fillet M; Pochet L
    Eur J Med Chem; 2020 Dec; 208():112753. PubMed ID: 32883641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk.
    Bach J; Endler G; Winkelmann BR; Boehm BO; Maerz W; Mannhalter C; Hellstern P
    J Thromb Haemost; 2008 Feb; 6(2):291-6. PubMed ID: 18021303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structures of the recombinant β-factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics.
    Pathak M; Manna R; Li C; Kaira BG; Hamad BK; Belviso BD; Bonturi CR; Dreveny I; Fischer PM; Dekker LV; Oliva MLV; Emsley J
    Acta Crystallogr D Struct Biol; 2019 Jun; 75(Pt 6):578-591. PubMed ID: 31205020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
    Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
    Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of factor XII in acetone-treated human plasma: significance of the functional state of plasma kallikrein for the extent of activation.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):144-50. PubMed ID: 3490738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moderation of prekallkrein-factor XII interactions in surface activation of coagulation by protein-adsorption competition.
    Chatterjee K; Thornton JL; Bauer JW; Vogler EA; Siedlecki CA
    Biomaterials; 2009 Oct; 30(28):4915-20. PubMed ID: 19552950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential-mediated and time-controlled first order activation of factor XII (Hageman factor) adsorbed to carbon surfaces.
    Randriamahazaka HN; Nigretto JM
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):567-73. PubMed ID: 7841313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma contact activation by a fucosylated chondroitin sulfate and its structure-activity relationship study.
    Lin L; Xu L; Xiao C; Zhou L; Gao N; Wu M; Zhao J
    Glycobiology; 2018 Oct; 28(10):754-764. PubMed ID: 30016441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contact activation-induced complex formation between complement factor H and coagulation factor XIIa.
    Thangaraj SS; Christiansen SH; Graversen JH; Sidelmann JJ; Hansen SWK; Bygum A; Gram JB; Palarasah Y
    J Thromb Haemost; 2020 Apr; 18(4):876-884. PubMed ID: 31984663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of surface-immobilized heparin on the activation of adsorbed factor XII.
    Elgue G; Sanchez J; Egberg N; Olsson P; Riesenfeld J
    Artif Organs; 1993 Aug; 17(8):721-6. PubMed ID: 8215954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FXII.
    Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE
    Blut; 1990 Nov; 61(5):258-66. PubMed ID: 2271772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics.
    Heestermans M; Naudin C; Mailer RK; Konrath S; Klaetschke K; Jämsä A; Frye M; Deppermann C; Pula G; Kuta P; Friese MA; Gelderblom M; Sickmann A; Preston RJS; Nofer JR; Rose-John S; Butler LM; Salomon O; Stavrou EX; Renné T
    Nat Commun; 2021 Sep; 12(1):5596. PubMed ID: 34552086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.